Determination of a cost-effectiveness threshold for cancer interventions in Iran
Background and objectivesThe estimation of a cost- Effectiveness (CE) threshold from the perspective of those who have experienced a life-threatening disease can provide empirical evidence for health policy makers to make the best allocation decisions on limited resources. The aim of the current stu...
Main Authors: | Hossein Safari, Thomas G. Poder, Somayeh Afshari, Azin Nahvijou, Morteza Arab-Zozani, Nasrin Moradi, Hosein Ameri |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1039589/full |
Similar Items
-
Determination of a willingness-to-pay threshold and decision-making in financing the healthcare technologies
by: T. S. Teptsova, et al.
Published: (2018-11-01) -
An exploratory study to estimate cost-effectiveness threshold value for life saving treatments in western Iran
by: Najmeh Moradi, et al.
Published: (2020-10-01) -
Willingness to pay for one quality-adjusted life year in Iran
by: Najmeh Moradi, et al.
Published: (2019-02-01) -
Mothers’ preferences and willingness-to-pay for human papillomavirus vaccines in Iran: A discrete choice experiment study
by: Nasrin Sargazi, et al.
Published: (2021-09-01) -
International experience in determining the cost-effectiveness thresholds
by: T. P. Bezdenezhnykh, et al.
Published: (2019-01-01)